Select a medication above to begin.
Dyanavel XR
amphetamine
Black Box Warnings .
Abuse, Misuse, and Addiction
CNS stimulants have high potential for abuse and misuse, can lead to substance use disorder, incl. addiction; misuse and abuse can result in overdose and death, risk incr. w/ higher doses or unapproved admin. methods; assess risk for abuse, misuse, and addiction before prescribing and throughout tx; educate pts and families about risks and proper drug storage and disposal; monitor frequently for s/sx of abuse, misuse, and addiction during tx
Adult Dosing .
Dosage forms: ER TAB: 5 mg, 10 mg, 15 mg, 20 mg; ER SUSP: 2.5 mg per mL
Special Note
- [formulation clarification]
- Info: amphetamine ER products not interchangeable; do not substitute on a mg to mg basis; retitrate if switching between products
ADHD
- [2.5-20 mg PO qam]
- Start: 2.5-5 mg PO qam, may incr. by 2.5-10 mg/day q4-7 days; Max: 20 mg/day
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
- Dosage forms: ER TAB: 5 mg, 10 mg, 15 mg, 20 mg; ER SUSP: 2.5 mg per mL
Special Note
- [formulation clarification]
- Info: amphetamine ER products not interchangeable; do not substitute on a mg to mg basis; retitrate if switching between products
ADHD
- [6 yo and older]
- Dose: 2.5-20 mg PO qam; Start: 2.5-5 mg PO qam, may incr. by 2.5-10 mg/day q4-7 days; Max: 20 mg/day
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]